Home › Medivir Announces That Janssen Has Started a Phase IIa Study to...
 

Keywords :   


Medivir Announces That Janssen Has Started a Phase IIa Study to...

2015-10-16 18:07:48| Appliances - Topix.net

Medivir AB today announces that Alios BioPharma Inc., part of the Janssen Pharmaceutical Companies , has started a phase IIa clinical trial to evaluate the combination of simeprevir, odalasvir , and AL-335 in treatment-nai 1 2ve patients with genotype 1 chronic hepatitis C virus infection. This phase IIa study is a randomized, open-label, three-arm study of AL-335, a nucleotide-based HCV NS5B polymerase inhibitor, odalasvir, an HCV NS5A inhibitor and simeprevir, an HCV NS3/4A protease inhibitor.

Tags: to study started phase

Category:Consumer Goods and Services

Latest from this category

All news
15.11Health stocks hit after Trump taps RFK for top job
15.11Typhoo Tea teeters on the brink of administration
15.11Pre-Budget nerves blamed as UK growth slows
15.11Bitcoin hacker sentenced to five years in prison
15.11Europe's flying taxi dreams falter as cash runs short
14.11UK must rebuild post-Brexit relations with EU, says Bank boss
14.11'I spend 30 a week on baby milk because I can't breastfeed'
14.11The Onion buys Alex Jones's Infowars at auction
Consumer Goods and Services »
15.11
15.11 BBM 25
15.11A-49-Black Roland MIDI
15.11
15.11DVD
15.11 22 C2500SXG
15.11Estoy Aqui
15.11WAWONA6 +
More »